Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: A systematic review [J]. Int J Infect Dis, 2010,14(11):e954-966.
[2]
Odds FC, Hanson MF, Davidson AD, et al. One year prospective survey of Candida bloodstream infections in Scotland [J]. J Med Microbiol. 2007,56(8):1066-1075.
[3]
Sardi JC, Scorzoni L, Bernardi T, et al. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options [J]. J Med Microbiol. 2013;62(1):10-24.
[4]
Godoy P, Tiraboschi IN, Severo LC, et al. Species distribution and antifungal susceptibility profile of Candida spp. blood-stream isolates from Latin American hospitals [J]. Mem Inst Oswaldo Cruz,2003,98 (3):401-405.
[5]
Colombo AL, Nucci M, Park BJ, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers [J]. J Clin Microbiol,2006,44 (8):2816-2823.
[6]
Kung HC, Wang JL, Chang SC, et al. Community-onset candidemia at a university hospital, 1995-2005 [J]. J Microbiol Immunol Infect, 2007,40(4):355-363.
[7]
Pahwa N, Kumar R, Nirkhiwale S, et al. Species distribution and drug susceptibility of Candida in clinical isolates from a tertiary care centre at Indore [J]. Indian J Med Microbiol,2014;,32(1):44-48.
Magaldi S, Mata S, Haitung C, et al. In vitro susceptibility of 137 Candida SPP. isolates from HIV positive patients to several anti-fungal drugs [J]. Mycopathologia, 2001,149(2) : 63-68.
[13]
Pfaller MA, Diekema DJ, Gibbs DL, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voricona- zole as Determined by CLSI Standardized Disk Diffusion [J]. J Clin Microbiol,2010,48 (4):1366-1377.
[14]
Yang YL, Ho YA, Cheng HH, et al. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis [J]. Infect Cont Hosp Ep,2004,25(1):60-64.
[15]
Yang YL, Wang AH, Wang CW, et al. Susceptibilities to amphotericin B and ?uconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006 [J]. Diag Microbiol Infect Dis, 2008,61 (2):175-180.
Vandeputte P,Larcher G,Bergès T. et al. Mechanisms of azole resistance in a clinical isolate of Candida tropicalis [J]. Antimicrob Agents Chemother,2005,49(11): 4608-4615.
[19]
Kimchi-Sarfaty C,Oh JM,Kim IW. et al .A"silent" polymorphism in the MDR1 gene changes substrate specificity [J].Science,2007,315(5811):525-528.
